Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)

Samsung Medical Center400 enrolled

Overview

This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Breast Cancer Metastatic Breast Cancer Radiation Therapy Complication

Eligibility

Sex: FEMALEMin age: 19 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * histologically confirmed breast cancer * presence of distant metastasis * radiation therapy using IMRT, SBRT, or proton therapy is done or planned * Able and willing to comply with the study protocol Exclusion Criteria: * unable to adhere to the study protocol

Locations (1)

Samsung Medical Center

Seoul, South Korea

RECRUITING

Outcomes

Primary Outcomes

Local control rate

LC after radiation therapy

Time frame: 1-year

Secondary Outcomes

Overall survival rate

Time frame: 1-year

Disease-free survival

disease-free survival rate after the time of RT

Time frame: 1-year

Treatment-related toxicities

Acute and chronic radiation toxicities according to CTCAE v5.0

Time frame: 1-year

Central Contacts

Haeyoung Kim

CONTACT

+82-02-3410-2612 haeyoung0131.kim@samsung.com

won kyung Cho

CONTACT

+821087328703 wklove.cho@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.